Empresa Puma Biotechnology Inc OTC Bulletin Board
Acciones
PBYI
US74587V1070
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Cancer Care Products
100,0
%
| 228 | 100,0 % | 236 | 100,0 % | +3,34 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 228 | 100,0 % | 236 | 100,0 % | +3,34 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/09/10 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 05/11/18 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/03/13 |
Investor Relations Contact | - | - | |
Jeffrey Ludwig
PRN | Corporate Officer/Principal | 58 | 01/03/20 |
Douglas Hunt
LAW | General Counsel | 59 | 01/01/18 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 23/02/18 |
Jay Moyes
BRD | Director/Board Member | 70 | 27/04/12 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/09/10 |
Director/Board Member | 63 | 29/07/22 | |
Director/Board Member | 60 | 11/08/15 | |
Troy Wilson
BRD | Director/Board Member | 55 | 18/10/13 |
Allison Dorval
BRD | Director/Board Member | 48 | 15/07/21 |
Brian Stuglik
BRD | Director/Board Member | 64 | 05/07/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 48 238 850 | 40 808 140 ( 84,60 %) | 0 | 84,60 % |
Información de la empresa
Puma Biotechnology, Inc.
10880 Wilshire Boulevard Suite 2150
90024-4101, Los Angeles
+
http://www.pumabiotechnology.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+51,85 % | 57,87 mil M | |
+41,42 % | 40,25 mil M | |
-5,25 % | 39,94 mil M | |
-5,16 % | 28,54 mil M | |
+12,79 % | 26,4 mil M | |
-20,18 % | 19,33 mil M | |
+30,88 % | 12,4 mil M | |
+0,61 % | 12,23 mil M | |
+25,06 % | 12,2 mil M |